Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-09-014038
Filing Date
2009-03-05
Accepted
2009-03-05 21:10:20
Documents
2
Period of Report
2009-02-27

Document Format Files

Seq Description Document Type Size
1 CAROL BAUM - FORM 3 - 2/27/2009 rrd236157.html 3  
1 CAROL BAUM - FORM 3 - 2/27/2009 rrd236157.xml 3 6971
2 POWER OF ATTORNEY rrd211776_239520.htm EX-24.1 3262
  Complete submission text file 0001181431-09-014038.txt   12102
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 8588758600
BAUM CAROL A (Reporting) CIK: 0001456456 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33415 | Film No.: 09660364